Hyperuricaemia and gout: state of the art and future perspectives.
Major progress has been made in the past decade in understanding the pathogenesis and treatment of gout. These advances include identification of the genetic and environmental risk factors for gout, recognition that gout is an important risk factor for cardiovascular disease, elucidation of the pathways regulating the acute gout attack and the development of novel therapeutic agents to treat both the acute and chronic phases of the disease. This review summarises these advances and highlights the research agenda for the next decade.
Dalbeth
Nicola
N
Bone and Joint Research Group, Department of Medicine, University of Auckland, Auckland, New Zealand.
So
Alexander
A
D000208:Acute Disease; D002318:Cardiovascular Diseases / Q000209:etiology; D004032:Diet; D004777:Environment; D006073:Gout / Q000188:drug therapy / Q000209:etiology*; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy / Q000209:etiology*; D012307:Risk Factors
D006074:Gout Suppressants